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 Natural polysaccharide-based biomaterials are currently being 
explored as novel drug delivery devices. Important properties of the 
polysaccharides include controlled biological activity and biodegradability. 
The tamarind seed is a by-product of the tamarind industry. The decorticated 
flour, known as tamarind kernel powder has been tried for various 
biomedical applications such as drug delivery carriers. The xyloglucan 
component of it, a hemicellulose, was found to be a biocompatible, non-toxic 
and cheap agro-based material that could be used safely for controlled drug 
delivery systems. Studies with tamarind-seed polysaccharide 
nanocomposites have been conducted, where tamarind and polyvinyl alcohol 
were blended with Cloisite 30B solution in different ratios showing a 
sustained delivery of drugs. We certainly foresee the prospect of bio-
adhesive carriers, such as muco-adhesive polymers of tamarind-seed 
polysaccharides an effective solution of achieving bioavailability of various 
ocular drugs when used as topical preparations. 
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Introduction 
 The recent use of biopolymers derived from agricultural feed stocks 
has attracted the attention of many researchers for various biomedical 
applications (Kalia S 2011). One such cheap and agro-based biomaterial is 
tamarind seed polysaccharide (TSP) obtained from tamarind seed. 
Tamarindus indica L, is a multipurpose tropical fruit tree primarily used for 
its fruits which are eaten fresh or processed to be used as a seasoning or 
spice. The fruits and seeds can also be processed for non-food uses. Recently 
various biodegradable based plants and animal based products have been 
explored for the use as drug carriers (Sahoo R 2010, Sahoo S 2010, Sahoo S 
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2011).Tamarindus indica L., commonly known as tamarind tree is one of the 
most important multipurpose tree species in the Indian sub-continent. It is a 
large evergreen tree with an exceptionally beautiful spreading crown, and is 
cultivated throughout almost the whole country, except in the Himalayas and 
western dry regions (ICFRE 1993, Rao Y S 1999). The major industrial use 
of the seeds is in the manufacture of TKP. It is prepared by decorticating the 
seed and pulverising the creamy white kernels (Khoja AK 2001).  
 However the medical use; especially the prospective use in drug 
delivery of TSP has not been reviewed extensively in literature. Therefore 
we wanted to have a review covering the various experimental studies those 
have explored the possibility of using TSP polysaccharides either through in-
vitro or in vivo studies. We searched the articles published & featured in 
Science direct through electronic search. All the studies covering the ocular 
drug delivery aspects were included in review. The studies mentioning drug 
delivery to other parts of body were excluded from this review. 
 
Tamarind Xyloglucan 
 Xyloglucan is a major structural polysaccharide in the primary cell 
wall of higher plants. Cell growth and enlargement are controlled by the 
looseness of a thin net of microfibrils made of cellulose. Xyloglucan cross-
links these cellulose microfibrils and provides the flexibility necessary for 
them to slide. (Glicksman M 1986). 
 
 
Figure.1 Biochemical Structure of Xyloglucan 
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 Purified, refined tamarind XG is produced in Japan and is permitted 
as a thickening, stabilizing, and gelling agent.spaceTamarind XG has a 
(1→4)-β-D-glucan backbone (Figure.1) that is partially substituted at the O-
6 position of its glucopyranosyl residues with α-D-xylopyranose (Gidley MJ 
1991). In DSC measurements, the gelation was detected as a peak that 
appeared at higher temperatures than a peak arising from helix-coil transition 
of gellan alone . It was also detected as a change in circular dichroism which 
was not observed in tamarind XG alone and gellan alone .Judging from the 
results it was concluded that tamarind XG and gellan may associate to form a 
gel network (Nitta Y 2003).  
 Kochumalayil et al (Kochumalayil JJ 2013) oriented 
bionanocomposite coatings with strong in-plane orientation of clay platelets 
for the first time prepared by continuous water-based processing. 
Montmorillonite (MTM) and a “new” unmodified biological polymer XG 
were combined. The resulting nanocomposites were characterized by field 
emission SEM, transmission electron microscopy (TEM), and x-ray 
defraction (XRD). XG adsorption on MTM was measured by quartz crystal 
microbalance analysis. Mechanical and gas barrier properties were measured, 
also at high relative humidity. The reinforcement effects were then modeled 
and XG dimensions in composites estimated using atomistic simulations. 
The nanostructure showed highly oriented and intercalated clay platelets . 
 
Mucoadhesive Properties of Tamarind seed polysaccharide (TSP) 
 Mucoadhesion is commonly defined as the adhesion between two 
materials, at least one of which is a mucosal surface. Over the past few 
decades, mucosal drug delivery has received a great deal of attention. 
Mucoadhesive dosage forms may be designed to enable prolonged retention 
at the site of application, providing a controlled rate of drug release for 
improved therapeutic outcome.TSP is a new formulation derived from the 
tamarind seed having mucoadhesive characterestics. The main component of 
tamarind seed has been identified as a non-ionic, neutral, branched 
polysaccharide consisting of a cellulose-like backbone that carries xylose 
and galactoxylose substituents (Saettone M 1997). The configuration of TSP 
gives the product a 'mucin-like' molecular structure, thus conferring optimal 
mucoadhesive properties (Mannucci LL 2000) .  
 Research has also shown that at the concentrations present in the 
ophthalmic formulations studied, TSP has an important characteristic that 
makes it similar to natural tears, whereby it is able to crystallise into a fern-
like shape (Mannucci LL 2004). It has been suggested that the similarity of 
the structure of TSP to endogenous mucin may allow a formulation 
containing this polymer to adhere readily to the ocular surface for prolonged 
periods and provide sustained relief from the symptoms of dry eye 
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(Burgalassi S 1999). Indeed studies undertaken to date suggest that TSP may 
have some benefits over hyalurnic acid in relation to ocular retention time, 
wound healing properties and relief of dry eye symptoms (Mannucci LL 
2000, Rolando M 2007). Overall, TSP has several physicochemical 
properties that make it suitable for the management of dry eye syndrome and 
which potentially have distinct advantages over currently available 
preparations.  
 Sahoo et al studied that the mucoadhesive polymer XG extracted 
from tamarind seeds could serve as a viscosity enhancer showing 
mucomimetic, mucoadhesive properties. The researchers described that 
several features make TSP an attractive candidate as a vehicle for ophthalmic 
medicaments for instance: (i) it is completely devoid of ocular toxicity; (ii) it 
has recently been put on the market as a tear fluid substitute because of its 
effectiveness in preventing alterations of the corneal surface for 
keratoconjunctivitis sicca; (iii) it increases the cornealwound healing rate; 
(vi) it reduces the in vitro toxicity exerted by timolol, methiolate, and 
fluoroquinolones on human conjunctival cells; and (v) it significantly 
increases the corneal accumulation and intraocular penetration of gentamicin 
and ofloxacin when administered topically to healthy rabbits (Sahoo S 2010). 
 
TSP for Drug Delivery System: 
 Amongst all of the hydrophilic polymers, polysaccharides have 
become most recognised due to their widespread uses. TSP in particular, is 
conventionally known to bind, stabilise, thicken, suspend and emulsify 
agents as well as enhance viscosity. Its role in wound healing and as a carrier 
in novel drug delivery systems via ocular, oral, buccal, and colonic routes 
has also become increasingly acknowledged. In addition, TSP also has non-
medical uses in nanofabrication, cosmetics and the food industry. Increasing 
discovery of the multiple roles of TSP has been possible due to its non-toxic 
nature and general acceptability by regulating authorities.  
 Other than the well-known uses of TSP, it has been identified to 
potentiate controlled release of both water soluble and water insoluble drugs. 
For instance, zero order release can be achieved by taking a sparingly soluble 
drug like indomethacin from TSP. The rate of release for these drugs can be 
controlled by using suitable diluents such as lactose and microcrystalline 
cellulose. Specific to water-soluble drugs, the release amount can also be 
controlled by partially cross-linking the matrix, here the degree of cross-
linking can be altered thus modifying the extent of drug release (Sumathi S 
2002). 
 Sahoo et al studied the nanocomposite of TSP in the controlled 
release of an anti-cancer drug, Paclitaxel (Sahoo R 2010). It was noticed that 
controlled delivery devices with biodegradable polymers had greater positive 
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significance over delivery systems that required surgical removal of the 
device. TSP as a biocompatible, non-toxic and cheap agro-based material 
was used safely for this controlled drug delivery system. A prolonged release 
of Paclitaxel was proven by use of TSP as the controlled release material. 
Swelling studies of the nanocomposites have also reported to be effective in 
releasing in a controlled manner.  
 
Use as Ocular Drug Release Modifiers 
 Much research is currently in progress studying the efficacy of TSP 
for ocular preparations. Few studies have reported that TSP could be useful 
as artificial tears for the treatment of dry eye syndrome due to its 
mucoadhesive properties and pseudoplastic rheological behaviour 
(Khounvilay K 2011, Rolando M 2007). Alongside this, the high viscosity 
and unique mucoadhesive strength of TSP make it an ideal candidate for 
increasing the pre-corneal residence time for many topical ocular 
preparations.  
 The effect of an ophthalmic preparation containing 0.5% timolol (β-
adrenergic blocker solution) plus 1 or 2% TSP on intraocular pressure (IOP) 
was evaluated in rabbits. It was concluded that timolol with TSP could be a 
good formulation for treating high IOP as the duration action of the 
formulation lasted for 12hours (D′amico M 1999). Similarly, another ocular 
drug pilocarpine, known to lower IOP has also been studied using tamarind 
gum as a novel bioadhesive material forming in situ gelling systems. The 
combination of alginate, tamarind gum and chitosan was identified as the 
most successful for sustained delivery of 80% of the drug for 12 hours. In 
vivo mitotic studies and ocular irritation studies have showed a significant 
long-lasting decrease in pupil diameter of rabbits with a well-tolerated non-
irritating effect with a tamarind gum based formulation (Mehra GR 2010).  
 Ghelardi et al (Ghelardi E 2010) employed ocular administration of 
hydrophilic and hydrophobic antibiotics such as gentamicin and ofloxacin 
using TSP as a mucopolysaccharide. When TSP viscosified solutions of the 
drug were instilled into rabbits, the aqueous humour and corneal 
concentration of the dose was remarkably higher than the drug itself. It was 
also noted that the absorption and drug elimination was prolonged by use of 
TSP, for example, the concentration of drug in the cornea exceeded the 
minimum inhibitory concentration (MIC) found in cases of 
keratoconjunctivitis.  
 Other studies have postulated the effectiveness of ocular delivery of 
antibiotics, rufloxacin and ofloxacin with mucoadhesive polymer extracted 
from tamarind seed, for the treatment of bacterial keratitis experimentally 
induced by Pseudomonas aeruginosa and Staphylococcus aureus in rabbits. 
They found that the formulation significantly increased the intra-aqueous 
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penetration of the drugs in both infected and uninfected eyes. The effect of 
TSP on delivery of rufloxacin for a significant reduction of bacteria in the 
cornea was better than using rufloxacin alone. This was most probable due to 
the prolongation of the pre-corneal residence time subsequently increasing 
drug availability (Khounvilay K 2011).  
 In order to mask the unpleasant odour and to prevent the fast 
degradation of the TSP, it has been subjected to chemical modification by 
treatment with various groups such as acetyl, hydroxyalkyl and 
carboxymethyl . In a study by Kaur et al (Kaur H 2012), nanoparticles of 
carboxymethyl tamarind kernel polysaccharide (CMTKP) were used for 
ophthalmic drug delivery. TSP was carboxymethylated in order to impart an 
anionic nature to the polymer; this helped to increase its viscosity with an 
increase in shelf life and decreased biodegradability. The solubility of TSP in 
cold water was also enhanced. In the study nanoparticles of CMTKP loaded 
with tropicamide were formed by an ionotropic gelation technique. The in 
vitro study result of tropicamide-loaded CMTKP nanoparticles showed no 
significant difference in the permeation of the nanoparticles compared to that 
of the aqueous solution of the drug. The formulation was found to be non-
irritant. 
 Uccello-Barretta et al (Uccello-Barretta G 2010) studied the 
interaction between TSP and hyaluronic acid (HA) with the aim of 
developing a promising excipient for ocular delivery. Nuclear Magnetic 
Resonance (NMR) spectroscopy was performed to determine the interaction 
between TSP and HA, this also helped to determine the optimum ratio of the 
TSP and HA in the mixture. A TSP:HA of 3:2in the mixture showed 
significant mucoadhesivity. An in vivo study on rabbits was also performed 
by the researchers, this was done by calculating the mean and maximum 
residence time of various TSP and HA mixtures in pre-corneal area. The 
results of these in vivo studies showed that the TSP:HA mixture in a 3:2 
ratio showed strong mucoadhesivity compared to individual components and 
other mixtures. They concluded in saying that the enhanced ocular drug 
availability by the TSP and HA mixture was attributed to the strong 
mucoadhesivity. The same authors also used ketotifen fumarate (KT) for the 
ophthalmic dosage forms which showed more favourable affinity towards 
TSP rather than towards hydroxyethylcellulose (HEC) or HA. The higher 
affinity of TSP compared to HEC and HA was demonstrated with the use of 
NMR spectroscopy and this result was confirmed by a dynamic dialysis 
technique, which showed that the fraction of KT bound to TSP was 
significantly higher than that bound to HEC or HA .This proves that KT with 
TSP helps in stabilising the tear film, and thus prolonging the residence time 
of KT tear fluid. The strong mucoadhesive nature of TSP is responsible for 
its enhanced ocular drug availability. 
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 Burgalassi et al (Burgalassi S 2000) carried out a study on corneal 
epithelium wound healing using TSP. TSP being a natural polymer helps in 
the adhesion of cells to laminin, thus promoting ocular wound healing. The 
work of these researchers on rabbits showed that TSP could help in would 
healing, although this was dependant on its varying concentrations.  
 
Conclusion 
 This review found that multiple previous studies have shown TSP 
used to have strong adsorption to cellulose. In addition, the basic 
characteristics of tamarind seed XG have been proven to be similar to those 
of plant cell wall XG. Furthermore, tamarind XG has a very high molar mass 
making it mechanically advantageous. This biodegradable 
glycosaminoglycan and a galactoxyloglucan polysaccharide have been found 
to have a wide application in the pharmaceutical industry for controlled drug 
delivery. The xyloglucan component has been described as a viscosity 
enhancer as it is mucomimetic and mucoadhesive. For ocular drug delivery, 
several features make TSP an attractive candidate as a drug delivery system. 
As mentioned earlier it’s non-toxic & mucoadhesive nature helps retaining 
topically applied drug for longer duration of action. One study shown the 
enhancement of penetration of drug to aqueous humour of eye when 
delivered through TSP. These dual properties like longer stay in cornea & 
permeability enhancer makes TSP as an ideal carrier for ocular drug 
delivery. Apart from its FDA approved commercial use as one of the tear 
substitutes , researchers have experimentally tried TSP & it’s nanocomposite 
for topical delivery of ocular drugs like Timolol, Fluoroquinolones, 
Gentamycin etc.  
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